BIRD Symposium - 19 September 2020
Platinum Sponsor 

Mylan has one of the industry’s largest and most diverse global portfolios: including 20 biosimilars and insulin analogs.
Our portfolio includes many of the top biologics globally and focuses on the areas of oncology, immunology, endocrinology and ophthalmology. Every biosimilar we add to our portfolio may help provide more patients in more countries with the treatment they need.
We are committed to continuing to invest in biosimilars.
Connect with us via LinkedIn!